Naim Alkhouri, MD, FAASLD, DABOM, is the chief of transplant hepatology and director of the Steatotic Liver Program at Arizona Liver Health.
New Hope and Persistent Challenges for MASH Treatment: Naim Alkhouri, MD
Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address patients' cirrhosis, explained Naim Alkhouri, MD.